Kari Tanderup PhD, MSc

Dr. Kari Tanderup, Ph.D., MSc, a Professor at the Department of Oncology, Aarhus University Hospital in Aarhus, Denmark. Tanderup was educated at Aarhus University with a master’s degree in physics and math in 1997. In 2008 Tanderup received Kari's Ph.D. degree with a thesis on brachytherapy in cervix cancer. Furthermore, since 2011, Tanderup has been appointed as visiting professor at the Medical University of Vienna.

At Aarhus University Hospital, Tanderup chaired a research group working with brachytherapy and MR image guidance. Kari's main research interests are MRI-guided cervix and prostate cancer, clinical studies, and in vivo dosimetry. Within these topics, Tanderup have authored 95+ papers and have supervised 10+ Ph.D. students. Furthermore, Tanderup was a committee member for the ICRU Report 89 on brachytherapy in cervix cancer, and Tanderup Associate Senior Editor for the International Journal of Radiation Oncology, Biology, and Physics.

Dr. Kari Tanderup is actively involved in committee and task group work in ESTRO and is the course director in the ESTRO school. Tanderup chairing the GEC ESTRO gyn network which represents the most active core European academic centers within gynecological brachytherapy and embraces members from Central/Eastern Europe, India, Canada, and the USA. Through past and ongoing activities this group is internationally recognized as a leading group in gynecological image-guided brachytherapy. The group has published international guidelines, which are now used worldwide. The GEC ESTRO GYN group has also coordinated the EMBRACE study, which is an international multicenter study on MRI-guided brachytherapy in cervix cancer. The EMBRACE trial has recruited 1417 patients, and this material is currently generating a wealth of clinical evidence on the outcome as well as dose and effect relationships.